Treatment Options for Vancomycin-Sensitive Enterococcus When Vancomycin Cannot Be Used
For vancomycin-sensitive Enterococcus infections where vancomycin is contraindicated due to drug reaction, linezolid 600 mg IV or PO every 12 hours is the primary recommended alternative across all infection types, with treatment duration dependent on the infection site and clinical response. 1
Site-Specific Treatment Recommendations
Bloodstream Infections
- Linezolid 600 mg IV or PO every 12 hours is the first-line alternative (strong recommendation, low quality evidence) 1
- High-dose daptomycin 8-12 mg/kg IV daily is an alternative option, particularly effective for persistent bacteremia 1
- Daptomycin can be combined with β-lactams (penicillins, carbapenems, or cephalosporins) for enhanced efficacy, especially when daptomycin MIC is 3-4 mg/mL 1
- Treatment duration: 10-14 days for uncomplicated bacteremia 1
Pneumonia
Complicated Intra-Abdominal Infections
- Linezolid 600 mg IV every 12 hours is the primary option 1
- Tigecycline 100 mg IV loading dose, then 50 mg IV every 12 hours is an alternative 1
- Treatment duration: 5-7 days based on source control and clinical response 1
Complicated Urinary Tract Infections
- Linezolid 600 mg IV every 12 hours 1
- Daptomycin 6-12 mg/kg IV daily is an alternative 1
- Treatment duration: 5-7 days 1
Uncomplicated Urinary Tract Infections
- Fosfomycin 3 g PO single dose or 3 g PO every other day 1
- Nitrofurantoin 100 mg PO four times daily 1
- Ampicillin 18-30 g/day IV in divided doses 1
- Amoxicillin 500 mg PO/IV every 8 hours 1
- Treatment duration: 3-7 days 1
Critical Clinical Considerations
Endocarditis Management
- For enterococcal endocarditis, vancomycin is traditionally combined with an aminoglycoside for synergy 2
- When vancomycin cannot be used, high-dose daptomycin (8-12 mg/kg) combined with β-lactams provides bactericidal activity necessary for endocarditis treatment 1, 3
- Cardiac surgery combined with antimicrobial therapy should be considered for infective endocarditis 1
Important Pitfalls to Avoid
- Do not delay appropriate therapy: Inappropriate antibiotic therapy significantly increases mortality (54% vs 26% at 30 days) and reduces median survival from 11 months to 1 month 4
- Linezolid limitations: Prolonged use causes time-dependent bone marrow suppression requiring monitoring of leukocyte counts 2, 3
- Daptomycin considerations: Use high doses (8-12 mg/kg) for serious infections; standard doses may be inadequate 1
- Tigecycline caveat: Only recommended for intra-abdominal infections, not for bacteremia or other systemic infections 1
Therapeutic Drug Monitoring
- For serious infections, therapeutic drug monitoring has the greatest evidence for predicting drug toxicity rather than efficacy for daptomycin and linezolid 5
- Monitor for linezolid-induced thrombocytopenia and anemia, especially with therapy >2 weeks 3